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Entryomains are important for successful infection by several viruses. However, their
role in the cell-entry process of human herpesvirus-6 (HHV-6) is unknown. Here we tested whether HHV-6
requires cell-membrane rafts for its entry. When cell-membrane rafts were disrupted by cholesterol
depletion, target-cell entry by HHV-6 was inhibited, although the virus bound normally to the cells. HHV-6
infectivity was partially rescued by adding exogenous cholesterol. Interestingly, the HHV-6 cellular receptor,
CD46, was found in the rafts after virus attachment, but not in the rafts of uninfected cells, indicating that
HHV-6 infection induces the re-location of its receptor into the rafts. Furthermore, glycoprotein Q1, part of a
viral glycoprotein complex that binds CD46, was also associated with rafts immediately after infection. These
data suggest that cellular-membrane lipid rafts are important in viral entry and that HHV-6 may enter the
target cells via the rafts.
© 2008 Elsevier Inc. All rights reserved.IntroductionHuman herpesvirus 6 (HHV-6) is a betaherpesvirus related to
human herpesvirus 7 (HHV-7) and human cytomegalovirus (HCMV).
First isolated from the peripheral blood of patients with AIDS and
lymphoproliferative disorders (Salahuddin et al., 1986), it is a human
pathogen of emerging clinical signiﬁcance. HHV-6 isolates can be
classiﬁed into at least two variants, variant A (HHV-6A) and variant B
(HHV-6B) (Ablashi et al., 1991; Chandran et al., 1992), based on their
genetic, antigenic, and growth characteristics. HHV-6B is the causative
agent of exanthem subitum (Yamanishi et al., 1988).
Approximately 15 to 20% of the plasma membrane surface area is
believed to consist of membrane lipid microdomains, called rafts
(Parolini et al., 1999; Schutz et al., 2000). The raft hypothesis states
that attractive forces between sphingolipids with saturated hydro-
carbon chains and cholesterol mediate the formation of these lateral
lipid assemblies in the otherwise unsaturated glycerophospolipid
environment of the cell membrane (Simons and Ikonen, 1997). Under
physiological conditions, the raft domains are small, and they are
associated with numerous cell processes, such as membrane trafﬁck-
ing and membrane signaling (Simons and Ikonen, 1997; Simons and
Toomre, 2000). The tight packaging of sphingolipids and cholesterol
with certain proteins forms microdomains with an increased
structural order, which are designed as liquid-ordered domains innd Vaccinology, Division of
nnovation, 7–6–8, Saito-Asagi,
l rights reserved.model membranes (Brown and Rose, 1992). These microdomains
resist solubilization by anionic detergents at 4°C and are therefore also
designated as detergent-resistant membrane microdomains (DRMs).
However, the extraction of cholesterol by various chemicals destroys
the raft organization and renders their components detergent-soluble.
An essential role for cholesterol in different aspects of the
replication cycle of viruses has been reported, especially during viral
entry (Manes et al., 2003; Rawat et al., 2003). For enveloped viruses,
cellular and viral membranes are involved in the fusion process.
Successful virus entry may require cholesterol in either membrane, or
in both, or may be cholesterol-independent. Murine leukemia virus
entry requires cholesterol in the cellularmembrane but not in the viral
envelope (Lu, Xiong, and Silver, 2002). However the reverse has been
reported for inﬂuenza virus (Sieczkarski andWhittaker, 2002; Sun and
Whittaker, 2003; Takeda et al., 2003). During the entry of herpes
simplex virus type 1 (HSV-1) and Varicella-Zoster virus (VZV),
cholesterol in both membranes is required (Bender et al., 2003;
Hambleton et al., 2007). On the other hand, receptor-mediated
endocytosis by vesicular stomatitis virus G protein-pseudotyped
retroviruses is lipid raft independent (Guyader et al., 2002; Katzman
and Longnecker, 2003; Popik et al., 2002).
Receptors for human immunodeﬁciency virus type 1 (HIV-1),
including CD4 (Xavier et al., 1998) and CCR5 (Manes et al., 1999), are
found in lipid rafts. Binding of the viral envelope glycoprotein gp120
to cells recruits even more HIV-1 receptors to the lipid rafts (Manes
et al., 2000; Popik et al., 2002). In contrast, in the case of infection by
HSV-1, neither its cellular receptors (HVEM and nectin-1) nor its
glycoprotein ligand, glycoprotein D (gD), are associated with lipid rafts
(Bender et al., 2003).
Fig. 2. The inhibitory effect of MβCD was partially reversed by exogenous cholesterol.
HSB-2 cells, untreated or treated with 2.5mM MβCD, were then incubated with
increasing amounts of cholesterol as described in Materials and Methods. (A) The cells
were subsequently infected with HHV-6A, and the expression of IE1 (immunolabeled
with AIE1) andα-tubulinwas detected in each sample 16h later byWestern blot. One of
three independent experiments is shown. (B) Quantitative analysis of Western blot by
KODAK MI software shows the intensity of the band relative to that obtained without
MβCD and cholesterol.
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and an HHV-6A envelope glycoprotein complex, consisting of
glycoprotein H (gH), glycoprotein L (gL), glycoprotein Q1 (gQ1), and
glycoprotein Q2 (gQ2), serves as the viral ligand for human CD46
(Akkapaiboon et al., 2004; Mori et al., 2003b). Although viral
membrane cholesterol is required for the entry of HHV-6A (Huang
et al., 2006), whether or not cholesterol is required in the cell mem-
brane remains to be elucidated, and it is unknown if human CD46 and
its viral ligand associate in the lipid rafts during HHV-6A entry.
Therefore, we investigated the role of lipid rafts in HHV-6 entry.
Here we showed that intact cholesterol on the cell membrane, as well
as the viral membrane, is required for the successful entry of HHV-6.
We also found that the receptor for HHV-6 is distributed in the lipid
rafts during viral entry. These observations suggest that lipid rafts in
the cellular membrane play an important role in the viral entry
process and that HHV-6 may enter target cells via the lipid rafts.
Results
Cholesterol depletion of target cells affects HHV-6 entry
One way to examine whether the lipid rafts on the target-cell
surface are important for virus entry is to deplete the cholesterol from
the cell surface with cholesterol-sequestering agents, such as MβCD.
We used this method to determine whether cholesterol on target cell
surfaces is required for HHV-6 entry. HSB-2 cells were treated with
various concentrations of MβCD for 30min at 37°C, and the drug was
then washed out. The pre-treated cells were infected with HHV-6,
washed to remove unbound virus, and cultured. Sixteen hours post-
infection, the expression levels of IE1 protein, an immediate early
protein, were determined by western blots probed with anti-IE1
(AIE1). As shown in Fig. 1A, the cholesterol depletion of HSB-2 had a
strong inhibitory effect on the infection that was noticeable even at
1mM MβCD. In fact, densitometry showed that the level of IE1 in theFig. 1. Effect of depleting cholesterol from HSB-2 cells on HHV-6 entry. HSB-2 cells were
incubated with increasing concentrations of MβCD, infected with HHV-6A, strain GS,
and lysed 16h post-infection as described in materials and methods. (A) Labeling with
an anti-IE1 antibody (AIE1) is shown on Western blot. Anti-tubulin antibody was used
as an internal control for the lysed proteins. One of three independent experiments is
shown. (B) Quantitative analysis of Western blot by KODAK MI software shows the
intensity of the band relative to that obtained with 0mM MβCD.cells treated with 1mM MβCD was approximately 50% of that in
untreated cells, and 40% and 20% of the control when 1.5mM or 2mM
MβCD was used, respectively (Fig. 1B). IE1 was detected faintly in cells
treated with 2.5mM or 3mM MβCD.
The viability of the MβCD-treated cells was examined by trypan
blue staining. Evenwith 3mMMβCD, there were only a few dead cells
compared with the untreated cells (data not shown), indicating that
the concentrations of MβCD used here had no signiﬁcant effect on
HSB-2 cell viability. Thus, the HHV-6 entry into HSB-2 cells was
inhibited in a dose-dependent fashion by MβCD.
Cholesterol replenishment restores the HHV-6 entry
To examine whether the effect of MβCD was permanent or
reversible and to conﬁrm that the effects of MβCD were solely due
to cholesterol depletion, exogenous cholesterol was used to
replenish the cell surface of MβCD-treated cells. After cholesterol
was removed from the cell surface by MβCD, various concentrations
of exogenous cholesterol were added to the cells. As shown in Fig. 2,
the addition of 0.1mM cholesterol to cells treated with 2.5mM
MβCD restored the expression of IE1. However, the IE1 levels were
lower than in cells that were not treated with MβCD, indicating that
the exogenous cholesterol was able to restore virus entry only
partially.
Cholesterol depletion does not prevent the cell-surface expression of the
CD46 receptor on HSB-2 cells
One possible explanation for the decreased IE1 expression
following cholesterol depletion (Fig. 1) is that CD46 expression on
the cell surface was downregulated by the treatment. To address this
question, we examined CD46 expression on the cell surface before and
after MβCD treatment. HSB-2 cells were incubated with or without
2.5mM MβCD, stained with an anti-CD46 antibody, and the CD46
expression was analyzed by FACS. As shown in Figure 3, there was no
Fig. 3. Cholesterol depletion did not affect the expression of CD46 on the surface of HSB-2 cells. HSB-2 cells were incubated with or without 2.5mMMβCD for 30min. The cells were
ﬁxed with 4% parafolmaldehyde for 15min at room temperature and stained with the mouse monoclonal antibody to CD46 followed by FITC-conjugated anti-mouse IgG. After the
incubation, the cells were washed twice with ice-cold PBS. Finally, the samples were suspended in ice-cold PBS (3% FCS added) and CD46 expressionwas analyzed on BD FACS Canto
(A). Image is one of three independent experiments. As a negative control, cells were incubatedwith FITC-conjugated anti-mouse (gray area). Quantiﬁcation of the results obtained by
ﬂow cytometry (B). Results are means from three independent experiments, with standard deviations. Asterisks indicate signiﬁcant (Pb0.01) values by the t test.
Fig. 4. Virus binding was not affected by cholesterol depletion from the target cell membrane. HSB-2 cells were incubatedwithout or with 2.5mMMβCD and then infectedwith HHV-
6A or mock infected as described in Materials and Methods. At 1h later, the cells were ﬁxed with 4% parafolmaldehyde for 15min at room temperature and stained with the mouse
monoclonal antibody to viral envelope glycoprotein, gB followed by FITC-conjugated anti-mouse IgG. After the incubation, the cells were washed twice with ice-cold PBS. Finally, the
samples were suspended in ice-cold PBS (3% FCS added), and binding to the target cells was conﬁrmed by the presence of gB, analyzed on BD FACS Canto (A). Mock-infected cells were
used as a negative control. Image is one of three independent experiments. Quantiﬁcation of the results obtained by ﬂow cytometry (B). Results are means from three independent
experiments, with standard deviations. Asterisks indicate signiﬁcant (Pb0.01) values by the t test.
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cells, indicating that cholesterol depletion did not affect the CD46
cell–surface expression.
Cholesterol depletion does not affect virus binding
Generally, the initial step of virus entry into a host cell is the
attachment of the virus to the cell surface, which is followed by the
fusion of the viral envelope with the cell membrane or by the
internalization of virus. Therefore, we explored the possibility that
MβCD treatment impairs the binding of HHV-6 to the cell surface.
Control HSB-2 cells (Fig. 4A) or HSB-2 cells treated with 2.5mMMβCD
(Fig. 4B) were washed and incubated with HHV-6 (dotted lines in Fig.
4) or were mock infected (solid lines in Fig. 4). Virion binding was
analyzed by FACS. The expression level of gB was essentially the same
in the MβCD-treated and untreated cells (Fig. 4). Therefore, the
depletion of cholesterol from the cell surface did not affect HHV-6’s
binding to the cell.
The HHV-6 receptor, CD46, associates with detergent-resistant
membrane microdomains (DRMs) during HHV-6 entry
HIV-1 infection triggers lateral membrane diffusion following the
engagement between the viral envelope ligand gp120 and the cellular
receptor CD4 (Manes et al., 2000). These membrane changes areFig. 5. CD46 detected in raft fractions during HHV-6 entry. HSB-2 cells were infected with p
obtained by spinning cell lysates through a linear sucrose gradient as described in Materials a
gradient) were analyzed onWestern blots probedwith an anti-EEA-1, anti-CD59, anti-CD46, a
HRF-coupled cholera toxin. Same amount of protein was used in each case, and EEA1 which
The results of same exposure times in HHV-6- and mock-infected cells were shown in each
membrane microdomains. (C) Electron micrograph of puriﬁed virion preparation, demonstrnecessary for infection, because the redistribution and clustering of
membrane microdomains enables the subsequent interaction of the
gp120-CD4 complex with its co-receptors. Therefore, we examined
whether the HHV-6A receptor, CD46, was present in the lipid rafts
following the initial virus association with the cell membrane or
during viral entry. To avoid confounds caused by other factors,
Histodenz gradient-puriﬁed virions (see Materials and Methods)
were used in this study, and the isolation of puriﬁed virions was
conﬁrmed by electron microscopy (Fig. 5C). HSB-2 cells were infected
with the puriﬁed HHV-6 virions (Fig. 5A) or mock infected (Fig. 5B).
At 1h post-infection, the cells were washed to remove the unbound
virions and lysed with Triton X-100. The lysates were spun through
a sucrose gradient (see Materials and Methods). The fractions con-
taining lipid rafts were identiﬁed by the speciﬁc markers GM1
(labeled by cholera toxin in Fig. 5) and CD59, which were detected
mainly within low-density fractions 4 and 5 from both HHV-6- and
mock-infected cell lysates (Fig. 5A and B). EEA1, a cellular marker of
the early endosome that does not associate with DRMs, was detected
exclusively in high-density fractions (11 and 12). Interestingly,
although CD46 was detected only in the high-density fractions in
the mock-infected cell lysates, in the HHV-6-infected cell lysates, it
was detected in the low-density fractions as well. These results
suggest that CD46 was distributed into the DRMs immediately after
HHV-6 attachment, and that the lipid rafts may play a role in virus
entry.uriﬁed HHV-6A virions (A) or mock infected (B) at 37°C for 1h. The raft fractions were
nd Methods. Bottom-loaded sucrose step gradients (fraction 1 represents the top of the
nti-gB or anti-gQ1 antibody. GM1, whichmigratedwith the dye front, was detectedwith
is usually detected in nonraft fractions was used as a signal control. “p” indicates pellet.
antibody. One of three independent experiments is shown. DRMs: detergent-resistant
ating that intact virions were used. Scale bar: 200nm.
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low-density sucrose fractions
The requirement for cholesterol for HHV-6 entry suggested that
the envelope proteins interacted with the lipid rafts. To test this
possibility, we looked for viral glycoproteins in the DRM-containing
fractions byWestern blot analysis. As shown in Fig. 5, gB and gQ1were
detected in the lipid raft fractions of HHV-6A-infected cells as well as
in the high-density fractions. Especially, gQ1, part of a viral
glycoprotein complex that binds CD46 was detected at higher levels
than gB in the lipid raft fractions. The other envelope glycoproteins, gL,
gH, gQ2, and gOwere assayed, butwere not detectable in the fractions.
This may be that they are expressed at lower levels or the titter of each
antibody used here is lower (data not shown). The results suggest that
viral envelope glycoproteins gQ1 and gB associate with cellular lipid
rafts during the entry process.
Discussion
Lipid rafts in the cell-surface membrane represent a privileged
microdomain that may facilitate virus entry. Lipid raft microdomains
are enriched in sphingolipids and cholesterol (Brown and Lyles, 2003;
Schutz et al., 2000; Simons and Ikonen, 1997; Simons and Ikonen,
2000; Takeda et al., 2003). The importance of cholesterol, an essential
constituent of rafts, in the viral envelope or the target cell membrane
during virus entry has been demonstrated for several viruses (Bender
et al., 2003; Hambleton et al., 2007; Huang et al., 2006; Lu et al., 2002;
Rawat et al., 2003; Sun and Whittaker, 2003). Depletion of cellular or
viral cholesterol can lead to the destruction of the structure of lipid
rafts and markedly reduce viral entry into cells. HIV-1, HSV, and VZV
require the cellar and viral membrane cholesterol (Bender et al., 2003;
Graham et al., 2003; Hambleton et al., 2007; Lee et al., 2003; Liao et al.,
2001; Liao et al., 2003; Manes et al., 2000), while the entry of other
viruses requires only one of the twomembranes to contain cholesterol
(Lu et al., 2002; Sieczkarski and Whittaker, 2002; Sun and Whittaker,
2003; Takeda et al., 2003).
Previously, we demonstrated the critical importance of viral
membrane cholesterol during the entry of HHV-6 (Huang et al.,
2006). Here, we showed that HHV-6 infectionwasmarkedly decreased
when the target (HSB-2) cells were treated with MβCD, an effective
cholesterol-depleting drug, indicating that successful HHV-6 infection
required cholesterol on both the viral and cellular membranes. The
addition of exogenous cholesterol to the target cellmembrane restored
virus infectivity, although partially, indicating that the decreased
infectivity was indeed due to the depletion of cholesterol from the cell
membrane. The partial recovery of infectivity is consistent with results
reported elsewhere (Imhoff et al., 2007). One possible explanation is
that, since only one form of exogenous cholesterol was added, other
forms of cholesterol depleted by MβCD, but that are needed for
efﬁcient viral entry, were not replenished.
For an enveloped virus, cell entry begins with attachment to the
target cell and ends with fusion between the viral envelope and the
cellular cytoplasmic or endosomal membrane. To conﬁrmwhich stage
of entry was affected by cholesterol depletion, we ﬁrst investigated its
inﬂuence on viral binding with the cellular membrane. No signiﬁcant
effect was detectable, indicating that the depletion of cholesterol from
target cells does not perturb the attachment of the virus to the cells,
but rather must alter entry events post-attachment, as reported for
other viruses (Hambleton et al., 2007).
The sensitivity of the virus to the cholesterol depletion may be
explained by the association of virus receptors with lipid rafts. The
tightly structured DRMs of the lipid rafts are resistant to ice-cold 1%
Triton X-100, whereas other cell membranes are soluble under these
conditions. Cellular protein CD46, a receptor for HHV-6, was not
detected in the DRMs of HSB-2 cells, except immediately after
exposure to HHV-6, when it was easily detected in them, indicatingthat CD46 is recruited into lipid rafts during HHV-6 entry. The re-
distribution of CD46 into the lipid rafts may be important for HHV-6
entry, especially for the post-attachment events.
The HHV-6A glycoprotein gQ1 is part of a heterotetrameric
complex, gQ1-gQ2-gH-gL, on the viral envelope (Akkapaiboon et al.,
2004; Mori et al., 2003a), that functions as a ligand for CD46 (Mori et
al., 2004; Mori et al., 2003b). Although the details of the interaction of
the complexwith CD46 are still unknown, herewe found that gQ1was
associated with the cellular lipid rafts during virus entry. We were
unable to detect the othermembers of the complex, gQ2, gH, and gL, at
all. Since gQ1 is generally abundant on the viral envelope, it may have
been easier to detect than the other glycoproteins. The association of
these viral glycoproteins with lipid rafts will need to be established to
clarify the role of the lipid rafts during virus entry. In the case of HSV-1,
its cellular receptors, HVEM and nectin-1, are not detected in lipid
rafts, nor is its viral ligand, gD (Bender et al., 2003). Therefore,
although both viruses use cellular membrane lipid rafts during entry,
they may differ in their ligand-receptor interactions and in how they
use lipid rafts.
During the entry of HSV-1, gB is associated with lipid rafts (Bender
et al., 2003), and this association may contribute to the entry process
of the virus. gB is one of ﬁve glycoproteins conserved throughout the
herpesvirus family (Singh and Compton, 2000; Spear and Longnecker,
2003). Although the function of gB during the entry of HHV-6 still
needs to be elucidated, we observed that HHV-6 gB was associated
with the DRMs during virus entry. HHV-6 gB may preferentially bind
to a raft-associated molecule and play a role following the engage-
ment of the cellular receptor and viral ligand.
The entry of virus into target cells is a complicated process. Here
we have elucidated some of the molecular details involved in HHV-6
target-cell entry. However, all of the molecular players may not be
accounted for yet, and besides CD46, HHV-6 may elicit the re-
distribution of other cellular molecules that are important for its entry
into rafts. Future studies will help identify the contributing viral and
cellular components and how they interact to effect viral entry.
Materials and methods
Cells and viruses
HSB-2 cells (T-cell line) were cultured in RPMI 1640 medium with
8% fetal calf serum (FCS). HHV-6A strain GS was propagated in HSB-2
cells, and the viral titers were estimated by the TCID50 method, using
HSB-2 cells. HHV-6 cell-free virus was prepared as described
previously (Dhepakson et al., 2002). Brieﬂy, when HHV-6-infected
HSB-2 cells showed evidence of N80% infection by immunoﬂuores-
cence assay (IFA), the cells were frozen and thawed twice, then spun at
2000×g for 10min. The supernatants were used as cell-free virus.
Puriﬁed virionswere prepared as follows. Supernatants containing the
virions from infected cells were collected (spun at 2500×g at 4°C for
15min) and the viruses were precipitated with 20% polyethylene
glycol (molecular mass 20kDa) in the presence of NaCl (0.9%). The
precipitates were resuspended, layered over a 5–50% Histodenz
(Sigma) linear gradient and spun for 1h at 27,000rpm (Hitachi
P40ST-1689 rotor, Hitachi High-Technologies). The fractions were
collected from the bottom, and the virus-containing fractions were
determined by a PCR analysis of the viral DNA.
Antibodies
Monoclonal antibodies (MAbs) against HHV-6A glycoproteins, anti-
gQ1 (AgQ1–119), anti-gL (AgL-2), anti-IE1 (AIE1), and anti-gB (OHV-1),
were described previously (Akkapaiboon et al., 2004; Huang et al.,
2006;Mori et al., 2003a). The rabbit antibody speciﬁc forHHV-6 gBwas
prepared as follows. Rabbitswere immunizedﬁve timeswith a puriﬁed
recombinant protein, named AgB-c. AgB-c was expressed as a
270 H. Tang et al. / Virology 378 (2008) 265–271glutathione S-transferase (GST) fusion protein and puriﬁed with
glutathione sepharose 4B (GE Healthcare). To prepare the fusion
protein, primers AgB2232bamF (5′’-accggatccacacctagtgttaaggatgttg)
and AgBsalR (accgtcgactcacgcttcttctacatttac; underlining indicates
restriction enzyme site) were used to amplify the insert from HHV-
6A DNA. The expression vector was made by inserting the PCR product
into the prokaryotic expression vector, pGEX-4T (GE Healthcare) at the
BamHI and SalI sites. The recombinant protein was expressed in E. coli
andpuriﬁed. TheB subunit of cholera toxin conjugatedwithﬂuorescein
isothiocyanate (FITC) was obtained from List Biological Laboratories.
Anti-CD46 (J4–48:Immunotech), anti-EEA-1 (clone 14: BD Biosciences)
and anti-CD59 (MEM-43: Serotec) MAbs were purchased.
Western blotting
Western blotting was performed as described previously (Akka-
paiboon et al., 2004).
Cholesterol sequestration and virus entry assay
HSB-2 cells were incubated for 30min at 37°C with serial dilutions
of methyl-β-cyclodextrin (MβCD) in cell culture medium. After being
washed with medium twice, the cells were infected with virus by
centrifugation at 2000×g at 37°C for 1h, then washed with medium
again. Sixteen hours later, the cells were harvested and lysed with 2x
sample buffer containing 32mM Tris/HCl (pH 6.8), 1.5% SDS, and 5%
glycerol. The proteins from the lysed cells were processed for Western
blotting.
Cholesterol replenishment
HSB-2 cells were treatedwith 2.5mMMβCD for 30min at 37°C and
washed, and cultured again with various amounts of Dihydrocholes-
terol (Sigma). After a 1-h incubation, the cholesterol-containing
medium was washed out, and the cells were infected with virus.
After 16h, the cells were lysed and processed for Western blotting.
Virus-binding assay
HSB-2 cells were incubated with or without 2.5mM MβCD for
30min at 37°C, washed twice with ice-cold medium, and incubated
with puriﬁed virus solution for 1h at 4°C. The cells were ﬁxed with 4%
parafolmaldehyde for 15min at room temperature, and stained with
themousemonoclonal antibody to gB (OHV-1,1:100) followed by goat
anti-mouse IgG-FITC (1:100). After the incubation, the cells were
washed twice with ice-cold PBS. Finally, the samples were suspended
in ice-cold PBS (3% FCS added) and the binding was analyzed on FACS
Canto (BD Biosciences).
Isolation of low-density detergent-insoluble membrane fractions on
sucrose gradients
Low-density detergent-insoluble membrane microdomains were
isolated essentially as described, with some modiﬁcations (Bender
et al., 2003; Kosugi et al., 2001; Nagafuku et al., 2003). Brieﬂy, 1×108
HSB-2 cells were infected with GS at 37°C for 1h, washed with ice-
cold PBS, and lysed with 1ml of ice-cold MNE buffer (25mM MES [2-
{N-morpholino}ethanesulfonic acid, pH 6.5], 150mM NaCl, 2mM
EDTA) containing 1% Triton X-100 (Fluka) with protease inhibitor
cocktail (Sigma). The cell lysates were further homogenized with 20
strokes in a Dounce homogenizer, and then incubated on ice for
20min. Next, the homogenized cell lysates were mixed with 1ml 80%
sucrose (prepared in MNE) and placed at the bottom of an
ultracentrifuge tube. A discontinuous gradient was formed by over-
laying the homogenate sequentially with 6.5ml of 30% and 3.5ml of 5%
sucrose in MNE. The gradient was spun at 39,000rpm (Hitachi P40ST-1689 rotor, Hitachi High-Technologies) for 16h at 4°C, and fractions
were collected from the top. The fractions were analyzed on aWestern
blot.
Electon microscopy
The puriﬁed virions were spun at 20,000rpm (Hitachi P40ST-1689
rotor, Hitachi high-Technologies) for 2h, and ﬁxed with 4 parafor-
maldehyde plus 2.5 glutaraldehyde at room temperature for 1h.
Processing for electro microscopy (EM) was carried out as described
previously (Gabel et al., 1989).
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